Table 4 : Different patterns of Failure with concurrent chemoradiotherapy
among complete responders of group I (cisplatin treated patients) and
group II (cisplatin with paclitaxel treated patients).

Variables	Group 1 N=20 (%)	Group II N=26 (%)	P-value
Superficial recurrence	4 (20%)	2 (7.7%)	0.9
Muscle invasive recurrence	3 (15%)	2 (7.7%)
Pelvic recurrence	2 (10%)	1 (3.8%)
Distant metastasis	1 (5%)	1 (3.8%)